Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

9,793 public trials 1,785 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Active, not recruiting

Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer Who Have Received Endocrine Therapy

NCT05840211

Conditions
Breast Diseases, Breast Neoplasms, Locally Advanced or Unresectable Metastatic Breast Cancer, +5 more
Locations
  • Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers Chandler, Arizona, United States
  • Los Angeles Hematology Oncology Medical Group Los Angeles, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
View all 288 locations
View Trial Details
Active, not recruiting

Adjuvant PVX-410 Vaccine and Durvalumab in Stage II/III Triple Negative Breast Cancer

NCT02826434

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Massachusetts general Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, not recruiting

Study of AC699 in Patients With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Locally Advanced or Metastatic Breast Cancer

NCT05654532

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Site 08 Denver, Colorado, United States
  • Site 07 Orlando, Florida, United States
  • Site 02 Sarasota, Florida, United States
  • Site 06 Rockville, Maryland, United States
View Trial Details
Active, not recruiting

Palbociclib After CDK and Endocrine Therapy (PACE)

NCT03147287

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • University of Miami Miami, Florida, United States
  • Emory University - Winship Cancer Institute Atlanta, Georgia, United States
  • Northwestern University Chicago, Illinois, United States
  • Indiana University Indianapolis, Indiana, United States
View all 22 locations
View Trial Details
Active, not recruiting

Carboplatin +/- Nivolumab in Metastatic Triple Negative Breast Cancer

NCT03414684

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • The Stamford Hospital Stamford, Connecticut, United States
  • Eastern Maine Medical Center Bangor, Maine, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, not recruiting

A Study of BL-M02D1 in Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer or Other Solid Tumors

NCT05339685

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • The First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China
  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China
  • Zhujiang Hospital of Southern Medical University Guangzhou, Guangdong, China
  • The Second Affiliated Hospital of Guilin Medical University Guilin, Guangxi, China
View Trial Details

Related conditions